ArticleCancer research2023

Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma.

Giuseppina Arbore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.